Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients
نویسندگان
چکیده
BACKGROUND Postoperative nausea and vomiting (PONV) is one of the most common adverse outcomes after strabismus surgery. The primary outcome of this prospective, randomized, double-blind study was to compare the incidences of nausea or vomiting, and patient satisfaction of ondansetron and ramosetron after strabismus surgery under general anesthesia. The secondary outcome was to investigate whether the number of involved extraocular muscles (EOMs) in strabismus surgery was related to PONV. METHODS One hundred and five patients (aged 18-60 years) undergoing strabismus surgery were allocated randomly to one of the three groups: placebo, ondansetron, or ramosetron. Patients received 2 ml placebo, 4 mg ondansetron, or 0.3 mg ramosetron at the end of surgery. Each of the three groups was subdivided into two subgroups according to the number of EOMs involved in the surgery: subgroup S, single-muscle correction; subgroup M, multiple-muscle correction. The incidences of nausea or vomiting, and patient satisfaction at 2, 24 and 48 h after surgery were analyzed as primary outcome. With regard to subgroups S and M in the placebo, ondansetron and ramosetron groups, incidences of nausea or vomiting, and patient satisfaction at 2, 24 and 48 h after surgery were analyzed as seconadary outcome. RESULTS The incidence of nausea was significantly lower in the ramosetron group at 2 h (9.4 %) than in the placebo (45.2 %) and ondansetron (34.7 %) groups (P < 0.05). The incidence of nausea was also significantly lower in the ramosetron group at 24 h than in the other groups (P < 0.05). Patients in the ramosetron group were more satisfied at 2 h (8.11 ± 0.98) and 24 h (8.50 ± 0.67) after surgery than those in the other groups (P < 0.05). With regard to subgroups S and M in the placebo, ondansetron and ramosetron groups, there were no significant differences in either the incidence of nausea or patient satisfaction. CONCLUSION Ramosetron has superior antiemetic activity to ondansetron in adult strabismus surgery patients. The number of EOMs involved in strabismus surgery was not related to the incidence of PONV. TRIAL REGISTRATION Clinical Research Information Service (CRiS) Identifier: KCT0000688 . Date of registration: 27 February 2013.
منابع مشابه
The effect of ondansetron and atropine administration on postoperative nausea and vomiting and duration of recovery stay in patients who undergoing strabismus surgery
Background: Nausea and vomiting is one of the most common complications after the strabismus surgery. In this study, we evaluated the efficacy of atropine versus ondansetron administration on the incidence of postoperative nausea and vomiting and duration of recovery stay in patients undergoing this procedure. Methods: In this case-control study, 90 patients between 3 to 30 years old who were ...
متن کاملEfficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials
BACKGROUND Postoperative nausea and vomiting is a common side effect of general anesthesia. In this study, we performed a meta-analysis on the efficacy and safety of ramosetron versus ondansetron in the prevention of postoperative nausea and vomiting using the most recently published randomized controlled clinical studies. METHODS PubMed and EMBASE were searched for randomized controlled clin...
متن کاملComparative Study of the Effect of Midazolam, Ondansetron and their Combination in Prevention of Nausea and Vomiting after Strabismus Surgery: A Randomized Double-Blind Clinical Trial
Background and purpose: Postoperative nausea and vomiting is a common complication of anesthesia. The aim of this study was to compare the effect of midazolam, ondansetron and their combination in prevention of nausea and vomiting after strabismus surgery. Materials and methods: In this randomized double-blind clinical trial, 140 patients undergoing strabismus surgery were divided into four gr...
متن کاملComparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis
BACKGROUND Postoperative nausea and vomiting is a distressing complication of surgery, and 5-HT3 receptor antagonists are often prescribed to prevent it. Ondansetron is the agent typically administered to prevent postoperative nausea and vomiting. Although ramosetron has a longer duration of action than ondansetron, it remains unclear whether ramosetron is the more effective medication. We perf...
متن کاملA Comparative Study of Ondansetron versus Ramosetron on Post Operative Nausea and Vomiting in Gynecological Surgeries
Postoperative nausea and vomiting (PONV) is one of the most unpleasant and distressing symptoms which follow anaesthesia and surgery and lead to serious postoperative complications. PONV commonly occurs within 24 hours after surgery and can occur following general, regional, or local anaesthesia. Patients undergoing major abdominal surgery are especially prone to PONV, with reported incidences ...
متن کامل